Published in Proc Natl Acad Sci U S A on July 31, 2013
Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages. J Immunol (2015) 1.03
Hyaluronan modulates TRPV1 channel opening, reducing peripheral nociceptor activity and pain. Nat Commun (2015) 0.89
Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management. Mayo Clin Proc (2015) 0.81
Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord. Eur J Neurosci (2014) 0.80
Condition-specific role of colonic inflammatory molecules in persistent functional colorectal hypersensitivity in the mouse. Neurogastroenterol Motil (2014) 0.80
Prostaglandin E2 differentially modulates the central control of eupnoea, sighs and gasping in mice. J Physiol (2014) 0.80
Role of prostaglandins in spinal transmission of the exercise pressor reflex in decerebrated rats. Neuroscience (2014) 0.78
The effect of intra-articular botulinum toxin A on substance P, prostaglandin E2, and tumor necrosis factor alpha in the canine osteoarthritic joint. BMC Vet Res (2017) 0.75
The level of netrin-1 is decreased in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord (2016) 0.75
The protection of meloxicam against chronic aluminium overload-induced liver injury in rats. Oncotarget (2017) 0.75
Prostaglandin-mediated inhibition of serotonin signaling controls the affective component of inflammatory pain. J Clin Invest (2017) 0.75
Periaqueductal Grey EP3 Receptors Facilitate Spinal Nociception in Arthritic Secondary Hypersensitivity. J Neurosci (2016) 0.75
[Pharmacological aspects of pain research in Germany]. Schmerz (2015) 0.75
Cellular and molecular mechanisms of pain. Cell (2009) 9.36
Prostaglandin E receptors. J Biol Chem (2007) 5.29
Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature (2001) 4.82
The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci (1999) 4.35
Regulation of immune responses by prostaglandin E2. J Immunol (2012) 3.93
The cell and molecular basis of mechanical, cold, and inflammatory pain. Science (2008) 3.46
Sensitization in patients with painful knee osteoarthritis. Pain (2010) 3.18
Inflammation in osteoarthritis. Curr Opin Rheumatol (2011) 2.72
PGE2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. J Physiol (1996) 2.46
NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy. Proc Natl Acad Sci U S A (1998) 2.44
Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci (1998) 1.88
Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med (2003) 1.69
Molecular mechanisms of diverse actions of prostanoid receptors. Biochim Biophys Acta (1995) 1.60
Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. Arthritis Rheum (2008) 1.53
PGE(2) selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons. Nat Neurosci (2002) 1.44
The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol (2002) 1.44
Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord. Prog Neurobiol (2001) 1.37
Neural circuitry engaged by prostaglandins during the sickness syndrome. Nat Neurosci (2012) 1.35
Prostanoid receptor antagonists: development strategies and therapeutic applications. Br J Pharmacol (2009) 1.31
Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity. J Pharmacol Exp Ther (2006) 1.30
Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J Clin Invest (2005) 1.30
Mechanisms of chronic pain in osteoarthritis. Curr Rheumatol Rep (2012) 1.22
Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. J Neurosci (1994) 1.17
Direct activation of rat spinal dorsal horn neurons by prostaglandin E2. J Neurosci (2001) 1.07
N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists block the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint. J Neurophysiol (1993) 1.07
Central pain mechanisms in the rheumatic diseases: future directions. Arthritis Rheum (2013) 1.06
Changes in the effect of spinal prostaglandin E2 during inflammation: prostaglandin E (EP1-EP4) receptors in spinal nociceptive processing of input from the normal or inflamed knee joint. J Neurosci (2004) 0.99
Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis. J Allergy Clin Immunol (2008) 0.95
Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2. Arthritis Rheum (2008) 0.95
Selective activation of the prostanoid EP(3) receptor reduces myocardial infarct size in rodents. Arterioscler Thromb Vasc Biol (1999) 0.92
Role of prostaglandin receptor subtype EP1 in prostaglandin E2-induced nociceptive transmission in the rat spinal dorsal horn. Brain Res (2004) 0.88
Different effects of spinally applied prostaglandin D2 on responses of dorsal horn neurons with knee input in normal rats and in rats with acute knee inflammation. Neuroscience (2008) 0.88
Comparison of nociceptive behavior in prostaglandin E, F, D, prostacyclin and thromboxane receptor knockout mice. Eur J Pain (2008) 0.87
Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones. Br J Pharmacol (2005) 0.85
Effect of endotoxin treatment on the expression and localization of spinal cyclooxygenase, prostaglandin synthases, and PGD2 receptors. J Neurochem (2007) 0.84
Impact of cryopreservation on extracellular matrix structures of heart valve leaflets. Ann Thorac Surg (2006) 2.35
Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain (2010) 2.35
Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia (2005) 2.18
Mechanisms of pain in arthritis. Ann N Y Acad Sci (2002) 2.13
Descending control of persistent pain: inhibitory or facilitatory? Brain Res Brain Res Rev (2004) 2.03
Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. Cancer Res (2002) 2.02
Prevalence of PB1-F2 of influenza A viruses. J Gen Virol (2007) 1.88
Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids. Pain (2009) 1.74
Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med (2003) 1.69
Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils. Proc Natl Acad Sci U S A (2007) 1.68
Heartbeat evoked potentials mirror altered body perception in depressed patients. Clin Neurophysiol (2012) 1.66
A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat Genet (2013) 1.61
The autonomic brain: an activation likelihood estimation meta-analysis for central processing of autonomic function. J Neurosci (2013) 1.54
Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. Arthritis Rheum (2008) 1.53
Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci U S A (2002) 1.51
Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain. Arthritis Rheum (2007) 1.44
Laparoscopic dismembered pyeloplasty--the method of choice in the presence of an enlarged renal pelvis and crossing vessels. Eur Urol (2002) 1.43
Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice. Arthritis Res Ther (2011) 1.42
A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models. Arthritis Rheum (2009) 1.38
Joint pain. Exp Brain Res (2009) 1.29
The cytokine TNFalpha increases the proportion of DRG neurones expressing the TRPV1 receptor via the TNFR1 receptor and ERK activation. Mol Cell Neurosci (2007) 1.27
Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model. Lab Invest (2012) 1.20
Autonomy of autonomic dysfunction in major depression. Psychosom Med (2009) 1.13
Importance of the EP(1) receptor in cutaneous UVB-induced inflammation and tumor development. J Invest Dermatol (2006) 1.12
Current knowledge on PB1-F2 of influenza A viruses. Med Microbiol Immunol (2010) 1.12
Increased pain sensitivity in alcohol withdrawal syndrome. Eur J Pain (2009) 1.09
Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model. Cancer Res (2010) 1.08
Role of prostaglandin E receptor EP1 subtype in the development of renal injury in genetically hypertensive rats. Hypertension (2003) 1.08
Acupuncture--deep pain with an autonomic dimension? Neuroimage (2011) 1.07
Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen-glucose deprivation. Neurotox Res (2008) 1.05
A technical triade for proteomic identification and characterization of cancer biomarkers. Cancer Res (2004) 1.05
Acute and long-term effects of IL-6 on cultured dorsal root ganglion neurones from adult rat. J Neurochem (2005) 1.04
Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury. J Neuroimmunol (2007) 1.04
Discovery and identification of alpha-defensins as low abundant, tumor-derived serum markers in colorectal cancer. Gastroenterology (2005) 1.03
Spreading depression in the brainstem of the adult rat: electrophysiological parameters and influences on regional brainstem blood flow. J Cereb Blood Flow Metab (2007) 1.01
PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease. Neurobiol Aging (2011) 1.01
High-resolution two-photon excitation microscopy of ocular tissues in porcine eye. Lasers Surg Med (2008) 1.01
Cardiovascular and cardiorespiratory coupling analyses: a review. Philos Trans A Math Phys Eng Sci (2013) 1.01
Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice. Mol Pain (2010) 1.00
Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist. J Am Soc Nephrol (2002) 1.00
Update on peripheral mechanisms of pain: beyond prostaglandins and cytokines. Arthritis Res Ther (2011) 0.99
Changes in the effect of spinal prostaglandin E2 during inflammation: prostaglandin E (EP1-EP4) receptors in spinal nociceptive processing of input from the normal or inflamed knee joint. J Neurosci (2004) 0.99
Differential effects of locally and systemically administered soluble glycoprotein 130 on pain and inflammation in experimental arthritis. Arthritis Res Ther (2010) 0.99
Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia. J Neuroimmunol (2009) 0.99
Gait abnormalities differentially indicate pain or structural joint damage in monoarticular antigen-induced arthritis. Pain (2009) 0.99
Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development. Carcinogenesis (2004) 0.97
Tumor necrosis factor causes persistent sensitization of joint nociceptors to mechanical stimuli in rats. Arthritis Rheum (2010) 0.96
Reduced heat pain thresholds after sad-mood induction are associated with changes in thalamic activity. Neuropsychologia (2008) 0.96
The altered complexity of cardiovascular regulation in depressed patients. Physiol Meas (2010) 0.96
Blockade of voltage-gated calcium channels in rat inhibits repetitive cortical spreading depression. Neurosci Lett (2002) 0.95
The anti-inflammatory effects of sympathectomy in murine antigen-induced arthritis are associated with a reduction of Th1 and Th17 responses. Ann Rheum Dis (2011) 0.95
CT-guided biopsy of indeterminate renal cystic masses (Bosniak 3 and 2F): accuracy and impact on clinical management. Eur Radiol (2002) 0.95
Autonomic dysfunction in unaffected first-degree relatives of patients suffering from schizophrenia. Schizophr Bull (2009) 0.94
PGE2 exerts its effect on the LPS-induced release of TNF-alpha, ET-1, IL-1alpha, IL-6 and IL-10 via the EP2 and EP4 receptor in rat liver macrophages. Prostaglandins Other Lipid Mediat (2004) 0.94
Spinal interleukin-6 is an amplifier of arthritic pain in the rat. Arthritis Rheum (2012) 0.94
Linear and non-linear measures indicate gastric dysmotility in patients suffering from acute schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.93
Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications. Phys Med Biol (2009) 0.93
2-Aminoethyl diphenylborinate analogues: selective inhibition for store-operated Ca2+ entry. Biochem Biophys Res Commun (2006) 0.93
Pathophysiology of pain. Langenbecks Arch Surg (2004) 0.92
Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion. Carcinogenesis (2009) 0.92
Is the audiologic status of professional musicians a reflection of the noise exposure in classical orchestral music? Eur Arch Otorhinolaryngol (2007) 0.91
Interleukin-17 sensitizes joint nociceptors to mechanical stimuli and contributes to arthritic pain through neuronal interleukin-17 receptors in rodents. Arthritis Rheum (2012) 0.91
Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. Cancer Sci (2003) 0.91
Altered diurnal autonomic variation and reduced vagal information flow in acute schizophrenia. Clin Neurophysiol (2006) 0.91
PGD(2) DP1 receptor protects brain from ischemia-reperfusion injury. Eur J Neurosci (2007) 0.91
Prostaglandin D2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways. Eur J Immunol (2003) 0.91
Biomechanical performance of different cable and wire cerclage configurations. Int Orthop (2012) 0.91
Calcitonin gene-related peptide enhances TTX-resistant sodium currents in cultured dorsal root ganglion neurons from adult rats. Pain (2005) 0.90
Influence of age on linear and nonlinear measures of autonomic cardiovascular modulation. Ann Noninvasive Electrocardiol (2010) 0.90
Gastric dysmotility in healthy first-degree relatives of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.90
Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice. Age (Dordr) (2010) 0.89
Prostaglandin facilitates afferent nerve activity via EP1 receptors during urinary bladder inflammation in rats. Biomed Res (2006) 0.89
Spreading depression can be elicited in brain stem of immature but not adult rats. J Neurophysiol (2003) 0.89
Prostaglandin receptor EP4 in abdominal aortic aneurysms. Am J Pathol (2012) 0.88
Cardio-respiratory coupling in untreated patients with major depression. J Affect Disord (2012) 0.88
Relationship between periodontal condition and plasma reactive oxygen metabolites in patients in the maintenance phase of periodontal treatment. J Periodontol (2008) 0.88
PGF(2alpha) FP receptor contributes to brain damage following transient focal brain ischemia. Neurotox Res (2009) 0.88
The relation of ventromedial prefrontal cortex activity and heart rate fluctuations at rest. Eur J Neurosci (2009) 0.87
Suppressive effect of an inducible nitric oxide inhibitor, ONO-1714, on AOM-induced rat colon carcinogenesis. Nitric Oxide (2005) 0.87